DolPHIN-2 presents on depressive symtoms at CROI 2024

Wendy van der Wekken-Pas presented on behalf of DolPHIN-2 the results from a sub study at CROI2024.  A high rate of depressive symptoms and poor sleeping quality were observed in the pregnant women recently diagnosed with HIV.  No differences were noted between DTG or EFV.